I'd rather focus on the future and not the past. Cash in hand is big plus, yet gaining more market share in Chinese competitive markets and more expensive but sustainable channels being developed, US FDA approval and A2 Platinum to be available in US during summer (August). Net profit growing, margins growing and cash flow positive are positives...
I'd rather focus on the future and not the past. Cash in hand is...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.13 |
Change
0.070(1.16%) |
Mkt cap ! $4.431B | |||
| Open | High | Low | Value | Volume |
| $6.06 | $6.13 | $6.04 | $8.538M | 1.400M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $6.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.13 | 29909 | 5 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$6.10 |
Change
0.070 ( 0.58 %) |
||||
| Open | High | Low | Volume | ||
| $6.08 | $6.11 | $6.03 | 348783 | ||
| Last updated 15.59pm 07/05/2024 ? | |||||
| A2M (ASX) Chart |